Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigate the Real-life Treatment Outcome of Regorafenib in Treating mCRC Patients

NCT03829852 is registered in ClinicalTrials.gov with Taipei Veterans General Hospital, Taiwan as lead sponsor.

NCT NCT03829852
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03829852 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigate the Real-life Treatment Outcome of Regorafenib in Treating mCRC Patients
Lead sponsor
Taipei Veterans General Hospital, Taiwan
Phase
Observational
Overall status
Completed
Start date
February 11, 2019
Completion date
December 8, 2020
Enrollment
716 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic colorectal cancer